2012 World BSAVA Congress
“BSAVA is a jewel in the crown of our profession,” says BSAVA President Mr Andrew Ash during the 2012 World BSAVA Congress opening ceremony on Wednesday 11th of April in Birmingham.
Posted on Apr 23, 2012 - 11:21 AM
History
Loading the player ...
Norbrook® Laboratories Ltd was founded by the current Chairman and CEO, Lord Ballyedmond, in the late 1960's, when he pioneered contract manufacturing of pharmaceuticals in the UK. Since then Norbrook has grown to be a worldwide leader in veterinary finished dose form products, medical finished dose form products and bulk pharmaceutical synthesis, making them a leader in the world in the production of pharmaceutical raw materials.
Most recently the company launched Closamectin Pour On, which has revolutionised the treatment of large animals for parasites (for more information about Closamectin visit www.closamectin.com). This is the only product available in Europe for treating parasites including fluke, by pouring it on the back of the animal. Norbrook has a large pipeline of new products which will be coming to the world market from December of this year, which we believe will put Norbrook in the forefront of novel product development in the next decade and beyond.
History of Norbrook
| 1969 | Norbrook was founded. |
| 1970 | Norbrook began manufacture of veterinary pharmaceuticals |
| 1974 | The first Norbrook patent was granted |
| 1978 | Norbrook expanded into Africa |
| 1980 | Norbrook expanded into Japan |
| 1987 | Norbrook received its first Queens Award for Export |
| 1990 | Norbrook expanded into Eastern Europe |
| 1994 | Norbrook announced its £38m expansion programme |
| 1996 | Norbrook expanded into People’s Republic of China |
| 1998 | Norbrook expanded into medical and raw material pharmaceutical production |
| 2000 | Norbrook expanded into Australia and New Zealand |
| 2001 | Norbrook launched their first major product for cats and dogs globally |
| 2002 | Norbrook received the Queens Award for Export Achievement for the fourth time |
| 2005 | Norbrook Laboratories announced Czech acquisition |
| 2006 | Norbrook’s novel combination of Ivermectin and Closantel received its license by the UK regulatory authorities. Norbrook invested £30m in a molecular development facility |
| 2007 | Norbrook announced an £83m investment in R&D |
| 2009 | Norbrook launched Closamectin Pour On for cattle |
| 2010 | Norbrook launched Closamectin Injection for sheep |
| 2011 | Norbrook received the Queens Award for Enterprise |
Latest News
Make Loxicom the highlight of your pet’s day!
"Not only does he love taking the medication straight from the syringe, but also the relief he gets from his stiffness is quite noticeable”.
Posted on Apr 16, 2012 - 03:23 PM
Closamectin Website Re-Launched to Support European Roll Out
Following the very successful launch of Closamectin Pour On in Europe, leading veterinary pharmaceuticals manufacturer, Norbrook Laboratories Ltd has re-launched www.closamectin.com.
Posted on Mar 09, 2012 - 11:41 AM
Norbrook Sponsors UK Dairy Expo
Leading veterinary pharmaceuticals manufacturer Norbrook Laboratories Ltd is delighted to be a main sponsor for the inaugural Borderway UK Diary Expo.
Posted on Feb 22, 2012 - 12:39 PM
-
View our Product Compendium
View our latest product compendium as an Ebook.
-
Veterinary Excellence Tool
Don't forget to review our app and tell us what you think.
-
Click Here to download the FREE Norbrook iPhone App!